Second Affiliated Hospital, Zhejiang University, School of Medicine: Observational study in Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer (1000 participants)
Second Affiliated Hospital, Zhejiang University, School of Medicine: Observational study in Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer (1000 participants). Its enrollment of 1,000 is top-decile (94th percentile of 8,879 records). Dated 7 days ago, it is inside the fresh trigger window. Score 65/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 1,000 · 94th percentile of 8,879 ClinicalTrialStartPulse records · 12.5x the median
Free preview: all 12 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine |
| Sponsor type | Academic and hospital |
| Study | SGA-OCRC: Prediction of 90-Day Major Adverse Postoperative Outcomes in Octogenarians With Resectable Colorectal Cancer |
| NCT ID | NCT07903129 |
| Phase | Observational |
| Status | not yet recruiting |
| Conditions | Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer |
| Target enrollment | 1000 |
| Posted | 2026-10-29 |
| Planned start | 2027-06 |
| Event | Newly registered study |
| Event date | 2026-10-29 |
| enrollment percentile | 94th of 8,879 (median 80, 12.5x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Second Affiliated Hospital, Zhejiang University, School of Medicine
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock Second Affiliated Hospital, Zhejiang University, School of Medicine + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-29
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Second Affiliated Hospital, Zhejiang University, School of Medicine and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Second Affiliated Hospital, Zhejiang University, School of Medicine's enrollment: 94th percentile of 8,879 records
- Timing: High: dated in the last 7 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
65 / 100 Score
- Posted in the last two weeks.
- 1000 participants planned.
- Not yet recruiting: vendors still being chosen.
What is the ClinicalTrialStartPulse record for Second Affiliated Hospital, Zhejiang University, School of Medicine?
Second Affiliated Hospital, Zhejiang University, School of Medicine registered a Observational study (NCT07903129) in Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer targeting 1000 participants, posted 2026-10-29.
How does Second Affiliated Hospital, Zhejiang University, School of Medicine compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 1,000 is 12.5x the median of 80 across 8,879 records. It is fresh: dated 7 days ago, inside the window where early outreach matters most.
Second Affiliated Hospital, Zhejiang University, School of Medicine vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | NONUS | 1,000 | 94th | 2026-10-29 |
| Janssen Pharmaceutica N.V., Belgium | NONUS | 1,314 | 95th | 2026-11-03 |
| Hoffmann-La Roche | NONUS | 1,800 | 96th | 2026-10-30 |
| Janssen-Cilag International NV | NONUS | 135 | 68th | 2026-11-03 |
Related records
ClinicalTrialStartPulse: Observational ClinicalTrialStartPulse: Outside the US only ClinicalTrialStartPulse: 1,000+
How to monitor Second Affiliated Hospital, Zhejiang University, School of Medicine and peer observational records
Get new ClinicalTrialStartPulse records like Second Affiliated Hospital, Zhejiang University, School of Medicine by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.